Literature DB >> 28194770

Clinical Pharmacology & Therapeutics: Past, Present, and Future.

S A Waldman1, A Terzic2.   

Abstract

Clinical Pharmacology & Therapeutics (CPT), the definitive and timely source for advances in human therapeutics, transcends the drug discovery, development, regulation, and utilization continuum to catalyze, evolve, and disseminate discipline-transformative knowledge. Prioritized themes and multidisciplinary content drive the science and practice of clinical pharmacology, offering a trusted point of reference. An authoritative herald across global communities, CPT is a timeless information vehicle at the vanguard of discovery, translation, and application ushering therapeutic innovation into modern healthcare.
© 2017 American Society for Clinical Pharmacology and Therapeutics.

Entities:  

Mesh:

Year:  2017        PMID: 28194770      PMCID: PMC5312263          DOI: 10.1002/cpt.592

Source DB:  PubMed          Journal:  Clin Pharmacol Ther        ISSN: 0009-9236            Impact factor:   6.875


  34 in total

1.  Therapeutic advances in idiopathic pulmonary fibrosis.

Authors:  G George; U Vaid; R Summer
Journal:  Clin Pharmacol Ther       Date:  2015-11-18       Impact factor: 6.875

2.  Precision Medicine.

Authors:  M Pacanowski; S M Huang
Journal:  Clin Pharmacol Ther       Date:  2016-02       Impact factor: 6.875

3.  Drug Transporters: Advances and Opportunities.

Authors:  R Govindarajan; A Sparreboom
Journal:  Clin Pharmacol Ther       Date:  2016-11       Impact factor: 6.875

4.  Biomedical Innovation: Lessons From the Past and Perspectives for the Future.

Authors:  B H Munos
Journal:  Clin Pharmacol Ther       Date:  2016-09-28       Impact factor: 6.875

5.  Organ Chips: Quality Assurance Systems in Regenerative Medicine.

Authors:  F S Pasqualini; M Y Emmert; K K Parker; S P Hoerstrup
Journal:  Clin Pharmacol Ther       Date:  2016-11-21       Impact factor: 6.875

6.  An International Asset Map of Clinicians, Educators, and Researchers Pursuing Better Medicine Use in Children: Initial Findings.

Authors:  S M MacLeod; Mje Greff; D C Knoppert; S Ito; M J Rieder
Journal:  Clin Pharmacol Ther       Date:  2016-09-28       Impact factor: 6.875

7.  Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing.

Authors:  K A Birdwell; B Decker; J M Barbarino; J F Peterson; C M Stein; W Sadee; D Wang; A A Vinks; Y He; J J Swen; J S Leeder; Rhn van Schaik; K E Thummel; T E Klein; K E Caudle; I A M MacPhee
Journal:  Clin Pharmacol Ther       Date:  2015-06-03       Impact factor: 6.875

Review 8.  Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for UGT1A1 and Atazanavir Prescribing.

Authors:  R S Gammal; M H Court; C E Haidar; O F Iwuchukwu; A H Gaur; M Alvarellos; C Guillemette; J L Lennox; M Whirl-Carrillo; S S Brummel; M J Ratain; T E Klein; B R Schackman; K E Caudle; D W Haas
Journal:  Clin Pharmacol Ther       Date:  2015-11-09       Impact factor: 6.875

9.  Between-Batch Pharmacokinetic Variability Inflates Type I Error Rate in Conventional Bioequivalence Trials: A Randomized Advair Diskus Clinical Trial.

Authors:  E Burmeister Getz; K J Carroll; J Mielke; L Z Benet; B Jones
Journal:  Clin Pharmacol Ther       Date:  2016-11-26       Impact factor: 6.875

10.  Batch-to-batch pharmacokinetic variability confounds current bioequivalence regulations: A dry powder inhaler randomized clinical trial.

Authors:  E Burmeister Getz; K J Carroll; B Jones; L Z Benet
Journal:  Clin Pharmacol Ther       Date:  2016-04-28       Impact factor: 6.875

View more
  1 in total

1.  Peer Review Certifies Quality and Innovation in Clinical Pharmacology & Therapeutics.

Authors:  S A Waldman; A Terzic
Journal:  Clin Pharmacol Ther       Date:  2017-09       Impact factor: 6.875

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.